Breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ

Chemoprevention with the antiestrogens, tamoxifen, raloxifene, and aromatase inhibitors, reduce breast cancer incidence in high-risk women; however, uptake has been poor (<5%) in the prevention setting. We assessed use of antiestrogens for breast cancer prevention, among high-risk women seen at a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast J
Hlavní autoři: Reimers, Laura L, Sivasubramanian, Parijatham S, Hershman, Dawn, Terry, Mary Beth, Greenlee, Heather, Campbell, Julie, Kalinsky, Kevin, Maurer, Matthew, Jayasena, Ramona, Sandoval, Rossy, Alvarez, Maria, Crew, Katherine D
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4490034/
https://ncbi.nlm.nih.gov/pubmed/25879521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tbj.12418
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky